Shacham Sharon 4
4 · Karyopharm Therapeutics Inc. · Filed Mar 31, 2022
Insider Transaction Report
Form 4
Shacham Sharon
CSO & Pres. Res. & Dev.
Transactions
- Award
Stock Option (right to buy)
2022-03-29+90,000→ 90,000 totalExercise: $10.33Exp: 2032-03-28→ Common Stock (90,000 underlying) - Award
Common Stock
2022-03-29+60,000→ 958,131 total
Holdings
- 713,757(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 28, 2023.
- [F2]This option was granted on March 29, 2022 pursuant to the Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.